Imaging of adrenal tumors using FDG PET: Comparison of benign and malignant lesions

Simone Maurea, Ciro Mainolfi, Lucio Bazzicalupo, Maria Rosaria Panico, Carmela Imparato, Bruno Alfano, Mario Ziviello, Marco Salvatore

Research output: Contribution to journalArticlepeer-review

Abstract

OBJECTIVE. The aim of this study was to differentiate benign from malignant adrenal tumors using positron emission tomography (PET) with 18F- fluorodeoxyglucose (FDG) in patients with unilateral adrenal masses originally detected by CT or MR imaging. CONCLUSION. PET imaging with FDG can metabolically characterize adrenal masses. Abnormally increased FDG uptake in adrenal malignancies allows one to differentiate these abnormalities from benign lesions. Whole-body PET can also reveal extraadrenal tumor sites in patients with malignant tumors, using a single imaging technique for accurate disease staging.

Original languageEnglish
Pages (from-to)25-29
Number of pages5
JournalAmerican Journal of Roentgenology
Volume173
Issue number1
Publication statusPublished - Jul 1999

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Fingerprint Dive into the research topics of 'Imaging of adrenal tumors using FDG PET: Comparison of benign and malignant lesions'. Together they form a unique fingerprint.

Cite this